The report provides a detailed analysis essential for establishing a Ferric Citrate production plant. It encompasses all critical aspects necessary for Ferric Citrate production, including the cost of Ferric Citrate production, Ferric Citrate plant cost, Ferric Citrate production costs, and the overall Ferric Citrate production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Ferric Citrate production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Ferric Citrate is applicable in the management of iron deficiency anemia in patients with chronic kidney disease who are not under hemodialysis and in the treatment of hyperphosphatemia in patients with chronic kidney disease on hemodialysis. Ferric Citrate acts as a phosphate blocker and increases phosphate excretion by the renal tubes while at the same time helping to maintain good phosphorus balance with reduced adverse effects such as cardiovascular diseases and bone diseases. It also serves as an iron supplement as it replaces the metal that has been used for the formation of red blood cells, thus decreasing symptoms of anemia.
The market for Ferric Citrate is attributed to its use in the treatment of iron deficiency anemia through supplementation, which is recommended for patients with CKD but not on dialysis, thereby contributing to the growth in the pharmaceutical and medical industry. The rising cases of chronic kidney disease are also driving the demand for Ferric Citrate. It witnesses a significant demand from the aging population who are more likely to be affected by CKD and iron deficiency.
In addition, its ability to function as a phosphate binder, preventing the absorption of dietary phosphate and assisting in the maintenance of healthy phosphorus levels, as well as lowering the risk of consequences, including cardiovascular disease and bone disease, amplifies its market appeal. Overall, industrial Ferric Citrate procurement is influenced by its utilization in the pharmaceutical and medical industries as an iron supplement, its application in CKD, the rising cases of CKD, the aging population, and its ability to function as a phosphate binder.
Raw Material for Ferric Citrate Production
According to the Ferric Citrate production plant project report, the key raw materials used in the production of Ferric Citrate include citric acid.
Production Process of Ferric Citrate
The extensive Ferric Citrate production cost report consists of the following major industrial production process:
- Production from citric acid: The production process of Ferric Citrate involves the reaction of citric acid with sodium hydroxide in water to form a sodium citrate solution. Ferric chloride hexahydrate is then added to the sodium citrate solution and stirred at a temperature of 50-55°C for about one hour to produce Ferric Citrate.
Ferric Citrate is a brown-colored powder having the molecular formula C6H5FeO7 and a molecular weight of 244.94 g/mol. It contains ferric ions (Fe³?) coupled with citrate ions produced from citric acid. It is hygroscopic, indicating it attracts moisture from the air and dissolves in water, generating a transparent solution. It remains stable for about three years at a temperature of 20 °C. Ferric Citrate solutions have a variable pH, although because citric acid is present, they are usually acidic.
